
What We’re Reading: mRNA Vaccine Effective Against Melanoma; Proposed Addiction Treatment Policy; Maternal Health Disparities Before Abortion Bans
Moderna’s mRNA-4157/V940 combined with Merck’s pembrolizumab reduced melanoma recurrence and death; HHS proposed permanently implementing emergency opioid use disorder policies enacted in 2020; maternal death rates were 62% higher in 2020 in states that now have abortion restrictions.
mRNA Vaccine Combined With Pembrolizumab Shows Promise for Melanoma Treatment
Moderna’s experimental mRNA cancer vaccine mRNA-4157/V940 combined with Merck’s cancer immunotherapy drug pembrolizumab was effective against
HHS, SAMHSA Propose Permanent Expanded Access for OUD Medications
HHS, through its Substance Abuse and Mental Health Services Administration (SAMHSA),
States With Abortion Bans, Restrictions Already Had High Maternal Death Rates
A study by the
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.